132464-90-5 Usage
Uses
Used in Organic Synthesis:
2-(5-Ethynylthien-2-yl)pyridine is utilized as a key intermediate in organic synthesis for the construction of complex organic molecules. Its unique structural features facilitate various chemical reactions, making it an indispensable component in the synthesis of advanced organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(5-Ethynylthien-2-yl)pyridine is employed as a building block for the development of novel drugs. Its electronic and aromatic properties contribute to the design of molecules with potential therapeutic applications, offering a promising avenue for the creation of new medications to address unmet medical needs.
Used in the Development of New Materials:
2-(5-ETHYNYLTHIEN-2-YL)PYRIDINE's unique properties also make it a valuable tool in the development of new materials with specific electronic or aromatic characteristics. This application extends to various industries that require materials with tailored properties for specialized uses.
Check Digit Verification of cas no
The CAS Registry Mumber 132464-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,4,6 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 132464-90:
(8*1)+(7*3)+(6*2)+(5*4)+(4*6)+(3*4)+(2*9)+(1*0)=115
115 % 10 = 5
So 132464-90-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H7NS/c1-2-9-6-7-11(13-9)10-5-3-4-8-12-10/h1,3-8H
132464-90-5Relevant academic research and scientific papers
Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2
Walser,Flynn,Mason,Crowley,Maresca,O'Donnell
, p. 1440 - 1446 (2007/10/02)
The preparations of thienotriazolodiazepines bearing a substituted ethynyl group at the 2-position, and the corresponding cis-olefins and fully saturated analogues are described. The compounds were evaluated as potential antagonists of platelet-activating